Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour
Data up to Jan 2025
Total Citations Per Year
Abstract
References (54)
Randomised trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. ISIS-2 (Second International Study of Infarct Survival) Collaborative Group.
1988 • 2,740 citations
EFFECTIVENESS OF INTRAVENOUS THROMBOLYTIC TREATMENT IN ACUTE MYOCARDIAL INFARCTION
1986 • 2,315 citations
Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 • 2,250 citations
Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients
1994 • 2,186 citations
The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs.
1977 • 1,927 citations
TRIAL OF TISSUE PLASMINOGEN ACTIVATOR FOR MORTALITY REDUCTION IN ACUTE MYOCARDIAL INFARCTION
1988 • 1,161 citations
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction. Results of the TIMI IIIB Trial. Thrombolysis in Myocardial Ischemia.
1994 • 1,003 citations
ISIS-3 - A RANDOMIZED COMPARISON OF STREPTOKINASE VS TISSUE PLASMINOGEN-ACTIVATOR VS ANISTREPLASE AND OF ASPIRIN PLUS HEPARIN VS ASPIRIN ALONE AMONG 41,299 CASES OF SUSPECTED ACUTE MYOCARDIAL-INFARCTION
1992 • 898 citations
ISIS-3: a randomised comparison of streptokinase vs tissue plasminogen activator vs anistreplase and of aspirin plus heparin vs aspirin alone among 41 299 cases of suspected acute myocardial infarction
1992 • 866 citations
Western Washington Randomized Trial of Intracoronary Streptokinase in Acute Myocardial Infarction
1983 • 805 citations
A Prospective Trial of Intravenous Streptokinase in Acute Myocardial Infarction (I.S.A.M.)
1986 • 705 citations
Prehospital-Initiated vs Hospital-Initiated Thrombolytic Therapy
1993 • 673 citations
Effect of Intravenous Streptokinase on Left Ventricular Function and Early Survival after Acute Myocardial Infarction
1987 • 628 citations
Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: Results of the TIMI IIIB trial
1994 • 498 citations
IMPROVED SURVIVAL AFTER EARLY THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
1985 • 450 citations
Prehospital Thrombolytic Therapy in Patients with Suspected Acute Myocardial Infarction
1993 • 402 citations
Intravenous tissue plasminogen activator and size of infarct, left ventricular function, and survival in acute myocardial infarction.
1988 • 386 citations
Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction
1993 • 361 citations
Cardiac rupture, mortality and the timing of thrombolytic therapy: A meta-analysis
1990 • 282 citations
The Western Washington Intravenous Streptokinase in Acute Myocardial Infarction Randomized Trial.
1988 • 246 citations
DOUBLE-BLIND RANDOMISED TRIAL OF INTRAVENOUS TISSUE-TYPE PLASMINOGEN ACTIVATOR VERSUS PLACEBO IN ACUTE MYOCARDIAL INFARCTION
1985 • 242 citations
Limitation of myocardial infarction by early infusion of recombinant tissue-type plasminogen activator.
1988 • 232 citations
Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian region early anistreplase trial. GREAT Group.
1992 • 230 citations
The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol
1996 • 189 citations
Acute myocardial infarction: pre-hospital and in-hospital management: The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology
1996 • 188 citations
Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction
1993 • 165 citations
Serial angiographic assessment of coronary artery obstruction and collateral flow in acute myocardial infarction. Report from the second Mount Sinai-New York University Reperfusion Trial.
1989 • 159 citations
Reperfusion in acute myocardial infarction: Effect of timing and modulating factors in experimental models
1993 • 147 citations
Time to thrombolytic treatment: Factors affecting delay and their influence on outcome
1995 • 140 citations
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
1986 • 135 citations
Temporal trends and factors associated with extent of delay to hospital arrival in patients with acute myocardial infarction: The Worcester Heart Attack Study
1994 • 127 citations
LATE assessment of thrombolytic efficacy with alteplase (rt‐PA) six‐24 hours after onset of acute myocardial infarction
1993 • 126 citations
Prehospital thrombolysis in acute myocardial infarction
1990 • 126 citations
Prehospital use of APSAC: Results of a placebo-controlled study
1989 • 126 citations
Implications for acute intervention related to time of hospital arrival in acute myocardial infarction
1986 • 124 citations
Tissue plasminogen activator: Toronto (TPAT) placebo-controlled randomized trial in acute myocardial infarction
1989 • 118 citations
Prevention of Myocardial Infarction by Very Early Treatment with Intracoronary Streptokinase
1984 • 112 citations
Myocardial reperfusion in the pig heart model: infarct size and duration of coronary occlusion
1987 • 101 citations
Influence of collateral blood flow and of variations in MV̇O2 on tissue-ATP content in ischemic and infarcted myocardium
1987 • 92 citations
Thrombolysis in patients with unstable angina improves the angiographic but not the clinical outcome. Results of UNASEM, a multicenter, randomized, placebo-controlled, clinical trial with anistreplase.
1992 • 90 citations
Tailored thrombolytic therapy. A perspective.
1993 • 84 citations
Very early thrombolytic therapy in suspected acute myocardial infarction
1990 • 79 citations
Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction
1990 • 70 citations
Prehospital thrombolysis with alteplase (rt-PA) in acute myocardial infarction
1992 • 67 citations
Comparison of intravenous urokinase plus heparin versus heparin alone in acute myocardial infarction
1991 • 59 citations
Treatment of acute myocardial infarction with anisoylated plasminogen streptokinase activator complex.
1986 • 46 citations
Determinants of infarct size in non-human primates
1990 • 44 citations
A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction.
1989 • 40 citations
Prehospital thrombolysis in a rural community: Short- and long-term survival
1992 • 31 citations
Very early thrombolytic therapy in suspected acute myocardial infarctionThe Thrombolysis in Acute Heart Attack Trial Study Group Am J Cardiol 65:401–407 Feb 1990
1990 • 19 citations
Thrombolytic Therapy Within One Hour of the Onset of Acute Myocardial Infarction
1991 • 11 citations
Thrombolysis in refractory unstable angina
1991 • 10 citations
Peaking time of creatine-kinase MB in patients treated with urokinase or conventionally during acute myocardial infarction: is it really a clue to reperfusion?
1988 • 2 citations
Fibrinolytic therapy in suspected acute myocardial infarction
1994 • 1 citations